Streetbeat News

Stock Prices

MS

Morgan Stanley's options trading shows a bearish sentiment among significant investors, with 47% of trades being bearish and 36% bullish. The trading activity suggests a price target range of $55.0 to $110.0. The stock is currently trading at $104.19 with a slight increase of 0.61%.

Portfolio Pulse from Benzinga Insights

July 26, 2024 | 8:15 pm

CGTX

Cognition Therapeutics, Inc. (NASDAQ:CGTX) will host an investor webcast on July 29, 2024, to discuss results from the Phase 2 SHINE study of CT1812 in mild-to-moderate Alzheimer's disease. The webcast will cover clinical efficacy, safety, and biomarker findings. Results will also be presented at the Alzheimer's Association's International Conference.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 8:13 pm

NDAQ

Nasdaq, Inc. (NDAQ) announced a secondary public offering of 41,604,207 shares held by Argus Seller, LP, and a share repurchase agreement to buy 1.2M shares for up to $120M. The repurchase is part of Nasdaq's existing program and will be funded by cash and borrowings.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 8:12 pm

RVSN

Rail Vision Ltd. (NASDAQ:RVSN) received a notification from Nasdaq indicating non-compliance with the minimum bid price requirement, as its share price has been below $1.00 for the last 30 consecutive business days.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 8:10 pm

RNAZ

TransCode Therapeutics' recent SEC 13G filing reveals that 3i, LP has reported a 9.9% stake in the company as of July 23, 2024.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 8:10 pm

HUDA

Hudson Acquisition I Corp. (NASDAQ:HUDA) has received a delisting notification from Nasdaq due to noncompliance with continued listing requirements. The company must appeal this decision to avoid delisting.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 8:08 pm

CMCSA

GOOG

GOOGL

Al Michaels will be featured as an AI-generated version of himself for Comcast's coverage of the 2024 Summer Olympics on Peacock. Google, through its Gemini AI, will partner with Team USA and Comcast to enhance Olympic coverage with advanced search and AI features.

Portfolio Pulse from Chris Katje

July 26, 2024 | 8:08 pm

SEEL

Seelos Therapeutics has announced that the Nasdaq Panel has granted their request for an additional period to regain compliance with Rule 5550(b)(2), allowing the company to remain listed on Nasdaq.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 8:05 pm

NAMS

NewAmsterdam Pharma (NASDAQ:NAMS) will report topline data from its Phase 3 BROOKLYN clinical trial evaluating Obicetrapib in patients with heterozygous familial hypercholesterolemia on July 29, 2024.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 8:02 pm

DAVE

Over the past three months, 10 analysts have evaluated Dave (NASDAQ:DAVE), with a mix of bullish and somewhat bullish ratings. The average 12-month price target has increased to $62.2, with a high of $75.00 and a low of $45.00. Dave has shown strong financial performance with significant revenue growth, high net margin, ROE, and ROA, and a prudent debt management strategy.

Portfolio Pulse from Benzinga Insights

July 26, 2024 | 8:02 pm